Literature DB >> 25268288

Overrepresentation of the ACTN3 XX genotype in elite canoe and kayak paddlers.

Joanna Orysiak1, Dariusz Sitkowski, Piotr Zmijewski, Jadwiga Malczewska-Lenczowska, Pawel Cieszczyk, Agnieszka Zembron-Lacny, Andrzej Pokrywka.   

Abstract

The aim of the study was to examine the association between the ACTN3 R577X polymorphism in canoe sprint athletes (canoe and kayak paddlers) and their results at 200- or 1000-m distance. Eighty-six European white male athletes divided into 2 groups-successful, who were outstanding at national championships, and nonsuccessful in these competitions-and 354 nonathletic controls were included in this study. The R577X polymorphism of ACTN3 was typed using PCR-RFLP. ACTN3 genotype distribution among all tested athletes and controls was in Hardy-Weinberg equilibrium. The odds ratio (OR) for successful 1000-m athletes harboring the XX genotype compared with sedentary controls was 2.95 (95% confidence interval [CI]: 1.37-6.35), but the OR for nonsuccessful 200-m athletes having the XX genotype compared with controls was 2.64 (95% CI: 1.30-5.36). These results suggest that factors associated with the ACTN3 XX genotype in canoe and kayak paddlers might provide some competitive advantage in performance at 1000 m, but it seems to limit at 200 m. Further studies aimed at development of training strategies based on genetic factors are needed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25268288     DOI: 10.1519/JSC.0000000000000717

Source DB:  PubMed          Journal:  J Strength Cond Res        ISSN: 1064-8011            Impact factor:   3.775


  4 in total

Review 1.  Rodent models for resolving extremes of exercise and health.

Authors:  Fleur C Garton; Kathryn N North; Lauren G Koch; Steven L Britton; Gisela Nogales-Gadea; Alejandro Lucia
Journal:  Physiol Genomics       Date:  2015-09-22       Impact factor: 3.107

2.  ACTN3 X-allele carriers had greater levels of muscle damage during a half-ironman.

Authors:  Juan Del Coso; Juan José Salinero; Beatriz Lara; César Gallo-Salazar; Francisco Areces; Carlos Puente; David Herrero
Journal:  Eur J Appl Physiol       Date:  2016-12-02       Impact factor: 3.078

Review 3.  Rhabdomyolysis: a genetic perspective.

Authors:  Renata Siciliani Scalco; Alice R Gardiner; Robert Ds Pitceathly; Edmar Zanoteli; Jefferson Becker; Janice L Holton; Henry Houlden; Heinz Jungbluth; Ros Quinlivan
Journal:  Orphanet J Rare Dis       Date:  2015-05-02       Impact factor: 4.123

Review 4.  Effective utilization of genetic information for athletes and coaches: focus on ACTN3 R577X polymorphism.

Authors:  Naoki Kikuchi; Koichi Nakazato
Journal:  J Exerc Nutrition Biochem       Date:  2015-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.